ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

ClinicalTrials.gov ID: NCT05822830

Public ClinicalTrials.gov record NCT05822830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 20, 2026, 6:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Compared to Semaglutide in Adults Who Have Obesity or Overweight With Weight Related Comorbidities

Study identification

NCT ID
NCT05822830
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
751 participants

Conditions and interventions

Interventions

  • Semaglutide Drug
  • Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 20, 2023
Primary completion
Nov 12, 2024
Completion
Nov 12, 2024
Last update posted
Nov 25, 2025

2023 – 2024

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Cahaba Research Birmingham Alabama 35242
Cahaba Research - Pelham Pelham Alabama 35124
Southern California Dermatology, Inc. Santa Ana California 92701
Encompass Clinical Research Spring Valley California 91978
University Clinical Investigators, Inc. Tustin California 92780
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009
New Horizon Research Center Miami Florida 33165
ForCare Clinical Research Tampa Florida 33613-1244
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
L-MARC Research Center Louisville Kentucky 40213
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098
Prime Health and Wellness/SKYCRNG Fayette Mississippi 39069
StudyMetrix Research City of Saint Peters Missouri 63303
Palm Research Center Tenaya Las Vegas Nevada 89128
Palm Research Center Sunset Las Vegas Nevada 89148
Weill Cornell Medical College New York New York 10021
PharmQuest Greensboro North Carolina 27408
Lillestol Research Fargo North Dakota 58104
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069
Tribe Clinical Research, LLC Greenville South Carolina 29607
WR-Clinsearch, LLC Chattanooga Tennessee 37421
The University of Texas Health Science Center at Houston Bellaire Texas 77401
Dallas Diabetes Research Center Dallas Texas 75230
North Texas Endocrine Center Dallas Texas 75231
Biopharma Informatic, LLC Houston Texas 77043
PlanIt Research, PLLC Houston Texas 77079
Southern Endocrinology Associates Mesquite Texas 75149
Pinnacle Clinical Research San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05822830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2025 · Synced Apr 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05822830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →